Global UV Infection Control Devices Market Expected to Reach $525 Million by 2026

According to a new report published by Allied Market Research, titled, "UV Infection Control Devices Market by Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018–2026," the global UV infection control devices market size was valued at $317 million in 2018, and is projected to reach $525 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

UV infection control devices emit ultraviolet rays that can kill infection causing microorganisms present in various healthcare facilities such as hospitals, clinics, and others. Furthermore, there are different types of UV infection control devices available in the market. For instance, mobile UV infection control devices are portable and can be moved from one place to another easily. In addition, the devices have handles all around which aid in the movement of device from one location to another. However, station type UV infection control devices are designed to plug into a standard power outlet. Moreover, these devices work by reflecting UV light off the walls. This reflected light is then absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

Surge in government focus on infection control programs and increase in the prevalence of hospital acquired infections (HAI) are the major factors that contribute to the growth of the UV infection control devices market. Furthermore, rise in adoption of technologically advanced UV equipment further supplement the growth of the market. However, high cost of UV infection control devices and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the UV infection control devices market growth.

The global UV infection control devices market is segmented on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

By type, the mobile type segment holds the dominant position in 2018 and would continue to maintain the lead over the forecast period. This is attributed to its mobility; as the device is light and can be moved to different settings. In addition, the cost of mobile UV infection control devices is less expensive than the stationary IV infection control devices. Furthermore, these mobile units are specifically designed for the ease of use and elimination of human error. For instance, mobile UV infection devices are available with casters or with a handcarts for maximum mobility. Therefore, the factors aforementioned contribute to the growth of the market.

By end user, the hospital segment occupied the largest share of the UV infection control devices market in 2018 owing to factors such as rise in number of UV infection control devices are used in the medical devices due to surge in cases of hospital acquired infections. In addition, surge in number of hospitals worldwide is further supporting the market growth. Hospital segment is also the fastest growing end user segment in UV infection control devices market.

North America accounted for the major UV infection control devices market share in 2018 and is expected to continue this trend, owing to presence of well-established healthcare infrastructure, higher buying power, and high adoption of advanced medical equipment. In addition, rise in cases of hospital acquired infection (HAIs) is another major factor that boost the growth of the market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the highly populated countries, with China being the first and India the second most populated countries. Therefore, the region has the potential to offer a huge patient base which is expected to boost the growth of the Asia-Pacific UV infection control devices market.

Key Findings of the Study:

• By type, the mobile device segment occupied around half share of the global UV infection control devices market in 2018.
• By end user, the hospitals segment is anticipated to grow with the highest CAGR throughout the forecast period.
• By type, the others segment accounted for more than two-fifths share of the market in 2018.
• BY region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.